
Medsaic is a life sciences company utilizing proteomics in its novel micro array platform to create a range of diagnostics services which can form the centre point for personalized medicine. Medsaic's proprietary technology, DotScan, is a specialised product for the diagnosis of hematological malignancies, solid tissue tumors and autoimmune diseases. It is based on cell capture by micro arrays of antibodies bound to nitrocellulose-coated microscope slides. The company was originally formed by the




